PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,562,000 | -12.5% | 6,361,364 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $4,071,000 | -24.4% | 6,361,364 | -0.7% | 0.01% | -22.2% |
| Q1 2016 | $5,384,000 | -17.6% | 6,406,099 | 0.0% | 0.01% | -18.2% |
| Q4 2015 | $6,534,000 | -13.7% | 6,406,099 | -0.2% | 0.01% | -26.7% |
| Q3 2015 | $7,575,000 | -40.1% | 6,419,147 | -1.0% | 0.02% | -34.8% |
| Q2 2015 | $12,639,000 | +9.1% | 6,481,624 | -0.4% | 0.02% | +4.5% |
| Q1 2015 | $11,588,000 | -3.3% | 6,510,158 | 0.0% | 0.02% | -8.3% |
| Q4 2014 | $11,979,000 | -24.0% | 6,510,158 | 0.0% | 0.02% | -31.4% |
| Q3 2014 | $15,755,000 | -32.6% | 6,510,158 | +1.6% | 0.04% | -31.4% |
| Q2 2014 | $23,388,000 | -13.2% | 6,407,588 | +8.9% | 0.05% | -19.0% |
| Q1 2014 | $26,941,000 | +16.8% | 5,882,224 | -0.8% | 0.06% | +16.7% |
| Q4 2013 | $23,065,000 | -8.2% | 5,929,269 | +6.9% | 0.05% | -15.6% |
| Q3 2013 | $25,134,000 | +7.1% | 5,548,351 | +16.1% | 0.06% | -9.9% |
| Q2 2013 | $23,470,000 | – | 4,780,062 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 13,275,000 | $13,541,000 | 0.88% |
| Broadfin Capital, LLC | 3,338,570 | $3,405,000 | 0.21% |
| Spark Investment Management LLC | 229,600 | $234,000 | 0.03% |
| Baillie Gifford | 6,406,099 | $6,534,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 349,546 | $357,000 | 0.01% |
| A.R.T. Advisors, LLC | 80,108 | $81,000 | 0.00% |
| Psagot Value Holdings Ltd. | 101,876 | $103,000 | 0.00% |
| WEDBUSH SECURITIES INC | 18,000 | $18,000 | 0.00% |
| TFS CAPITAL LLC | 31,234 | $32,000 | 0.00% |
| VAN ECK ASSOCIATES CORP | 106,208 | $108,000 | 0.00% |